Urvi A. Shah,Kylee H. Maclachlan,Andriy Derkach,Meghan Salcedo,Kelly Barnett,Julia Caple,Jenna Blaslov,Linh Tran,Amanda Ciardiello,Miranda Burge,Tala Shekarkhand,Peter Adintori,Justin Cross,Matthew J. Pianko,Sham Mailankody,Neha Korde,Malin Hultcrantz,Hani Hassoun,Carlyn Tan,Sydney Lu,Dhwani Patel,Benjamin Diamond,Gunjan Shah,Michael Scordo,Oscar Lahoud,David J. Chung,Heather Landau,Saad Usmani,Sergio Giralt,Ying Taur,C. Ola Landgren,Gladys Block,Torin Block,Jonathan U. Peled,Marcel RM van den Brink,Alexander M. Lesokhin

Abstract:Abstract Sustained minimal residual disease (MRD) negativity is associated with long-term survival in multiple myeloma (MM). The gut microbiome is affected by diet, and in turn can modulate host immunity, for example through production of short-chain fatty acids including butyrate. We examined the relationship of dietary factors, stool metabolites, and microbial diversity with sustained MRD negativity in patients on lenalidomide maintenance. At 3 months, higher stool butyrate concentration (p=0.037), butyrate producers (p=0.025) and α-diversity (p=0.0035) were associated with sustained MRD-negativity. Healthier dietary proteins, (from seafood and plants), correlated with butyrate at 3 months (p=0.009) and sustained MRD-negativity (p=0.05). Consumption of dietary flavonoids, plant nutrients with antioxidant effects, correlated with stool butyrate concentration (anthocyanidins p=0.01, flavones p=0.01, and flavanols p=0.02). This is the first study to demonstrate an association between a plant-based dietary pattern, stool butyrate production and sustained MRD-negativity in MM; providing rationale to evaluate a prospective dietary intervention. Statement of Significance We demonstrate an association between diet, the gut microbiome, and sustained MRD-negativity in MM. A healthy diet, with adequate plant and seafood protein, and containing flavonoids, associates with stool diversity, butyrate production and sustained MRD-negativity. These findings suggest dietary modification should be studied to enhance myeloma control. Key Points In MM on lenalidomide maintenance, stool butyrate concentration at 3 months was associated with higher rates of MRD negativity at 12 months. Increased seafood and plant proteins, dietary flavonoids, and diversity of dietary flavonoids correlated with stool butyrate concentrations.

Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets